The problem in health care is not a lack of government control over prices. It is a lack of transparent prices altogether…

The Most Favored Patient policy blueprint, developed by economists Steve Moore, Steve Forbes, and others, expands on price transparency and direct-to-patient drug sales to further simplify and bring accountability and affordability to the health care system.

Supply-side reforms cannot work when consumers, employers, and providers are shielded from real price signals. It makes little sense for Republicans to pursue tax and regulatory relief while simultaneously embracing command-and-control pricing. As Republicans build an affordability agenda, they should resist the temptation to imitate left-wing economics dressed up as consumer protection.

We hope President Trump and Republicans in Congress follow this advice.